InCytu, Inc. is a therapeutic device engineering company developing immunotherapeutic and tissue regeneration products that are designed to transform personalized medicine. InCytu Incorporated is developing a family of intelligent biopolymer devices that accelerate healing, enhance tissue regeneration or focus the immune system to destroy cancer. Called Cellarium™, these in situ bioactive devices (iBDs) are made from existing, clinically understood materials and bio-molecules, and are protected by a broad, Harvard-developed (Prof. David Mooney et al), intellectual property portfolio.
